miReven Scientists Awarded $530k Grant to Advance miR-7 Cancer Therapeutic

miReven scientists have been awarded a $530,000 NHMRC Development Grant to advance miR-7 as a novel cancer therapeutic. Chief Investigators on the project Prof. Peter Leedman and Dr Christopher Wraight will apply the funding to the development of a series of novel miR-7 mimics with optimised drug-like properties. The project builds on the successful preclinical […]